(Q57384158)

English

One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample

article by Robin M. Carter et al published 2001 in Depression and Anxiety

In more languages

Statements

scholarly article

0 references

One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample (English)

0 references

clinical psychology

0 references

0 references

generalized anxiety disorder

1 reference

based on heuristic

inferred from title

Hans-Ulrich Wittchen

object named as

Hans-Ulrich Wittchen

2

0 references

Ronald C. Kessler

4

object named as

Ronald C. Kessler

0 references

author name string

Robin M. Carter

1

0 references

Hildegard Pfister

3

0 references

publication date

2001

0 references

Depression and Anxiety

0 references

13

0 references

78-88

0 references

2

0 references

Prevalence of minor psychiatric disorders in an adult African rural community in South Africa

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Psychiatric comorbidity in patients with generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

The empirical basis of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-olds.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

The Shatin community mental health survey in Hong Kong. II. Major findings

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Epidemiology of anxiety disorders in Florence.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

DSM-III-R disorders in New Zealand 18-year-olds.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Diagnosing major depression in the elderly: evidence for response bias in standardized diagnostic interviews?

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Structure, Content and Reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) Substance Use Sections

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Lifetime prevalence of specific mental disorders among people born in Iceland in 1931.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Phenomenology and course of generalised anxiety disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Prevalence of mental disorders and psychosocial impairments in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

21 January 2018

Somatic Symptom Index (SSI): A New and Abridged Somatization Construct

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalized anxiety disorder and its comorbidities: disputes at the boundaries.

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

A description of patients diagnosed with DSM-III-R generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.1020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.1020

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57384158&oldid=1806561794"